In this Section |
177497 Alcohol-related disease impact in KoreaTuesday, October 28, 2008
Aims: Aims of this study are to describe the alcohol-attributable fractions of each disease and alcohol-related death impacts, and to estimate the life expectancy lost by drinking.
Design and samples: This is the cross-sectional study. The Korean national samples were selected randomly from the National Statistical Office' data-set. We had 'face-to-face interview plus sealed envelope' with every adult family members in the household from the August 10th to 25th, 2007. The questionnaire was asked the respondents to answer a series of questions about their alcohol use and associated health problems, demographic and background characteristics. In conducting the data analysis, 2,193 cases were used. Mortality data were collected from 'Annual Report on the Cause of Death Statistics' in 2005. The materials are all classifiable data, 135,405 cases of male and 110,106 cases of female. Results: The Odds Ratio of the liver disease, like as steatosis, hepatic cirrhosis and hepatitis, also odds ratio of respiratory diseases, prostatitis, gastric ulcer, enteritis and pancreatitis are greater among the other diseases. Hepatic cirrhosis (67%), liver steatosis (72%), Enteritis (52%), pancreatitis (50%), and hepatitis (41%) have the highest the alcohol-attributable fractions among the other diseases. Alcohol-attributable fractions of other genitourinary disease (33%), other disease of respiratory system (27%), and Gastric ulcer (23%) are also somewhat high. The number of alcohol related deaths is 20,940 for male and 10,393 for female. The effect on life expectancy at birth of eliminating all causes of alcohol-related deaths is 2.32 years for male and 0.91 years for female.
Learning Objectives: Keywords: Alcohol, Alcohol Problems
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I am a principal investigator. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
See more of: Alcohol Issues in Special Populations: Exploring the Risk
See more of: Alcohol, Tobacco, and Other Drugs |